<p><b>A</b>) Tumor volume (mm3) in mice receiving anti-TNF-α mAb (dashed lines) or isotype IgG control (continuous lines) and injected with Cl-IB-MECA or PBS or CD8+ T cells treated or not with Cl-IB-MECA. <b>B</b>) Percentage of CD11c+CD207 high cells in the tissue of mice described above. <b>C</b>) Representative dot plot is shown. <b>D</b>) and <b>E</b>) Expression of CD80 and MHC I, respectively, on CD11c+CD207 high cells in the tissue of mice described above. Data are from two independent experiments and represent mean ± SEM, n = 9 for each experiment. Statistical difference was determined by one way ANOVA. *p<0.05, **p<0.01, ***p<0.001.</p
<p>(a) TNF-α concentration in the blood of <i>S.</i> Typhimurium-infected, CT26 tumor-bearing BALB/c...
<p><b>A</b>) and <b>B</b>) TNF-α and granzyme B levels, respectively, detected into tissue homogenat...
<p><b><i>1A</i></b><i>,</i> representative FACS plots for MDSC in blood, BM, spleen and tumor of 3LL...
<p>(<b>A</b>) Wt mice were inoculated with 1×10<sup>5</sup> B16-OVA cells and injected with 5×10<sup...
<p><b>A</b>) C57Bl6j mice were s.c. inoculated with 2.5×10<sup>5</sup>cells B16-F10 cells/mouse. 10 ...
<p>Tumor-bearing mice were treated with 10, 25 or 50 mg/kg of mAb AFS98 or PBS, IP, starting from da...
<p>F4/80 (A, B) or CD163 (C, D) expression in mammary tumors sampled at week 14 from mice treated wi...
Antibodies were administered locally into tumors again at days 2, 5, 8, and 11 after tumor transplan...
<p>Balb/c mice were inoculated with CT-26 cells and treated with WKYMVm, 5-FU, and mDCs according to...
<p>(<b>A</b>) CD8 TCRtg B6 mice injected with CD11c-scFv-IDRgag-treated bmDCs showed a significant h...
<p>Mice were subcutaneously immunized with PBS or TcdB-exposed CT26 cells (TcdB). In some experiment...
(A) EMT6 tumor growth measured as a tumor volume. (B) Percentage of intratumoral myeloid cells (in i...
C57BL/6 (WT) and PLT2 mice were challenged with B16.OVA tumor cells. CFSE-labelled OT-I T cells were...
<p>(<b>A</b>) Concentrations of various cytokines in ascites. A1, IL-6; A2, IL-12; A3, TNF-α; A4, IF...
C57BL/6 (WT) and PLT2 mice were challenged with B16 tumor cells and treated with peri-tumoral inject...
<p>(a) TNF-α concentration in the blood of <i>S.</i> Typhimurium-infected, CT26 tumor-bearing BALB/c...
<p><b>A</b>) and <b>B</b>) TNF-α and granzyme B levels, respectively, detected into tissue homogenat...
<p><b><i>1A</i></b><i>,</i> representative FACS plots for MDSC in blood, BM, spleen and tumor of 3LL...
<p>(<b>A</b>) Wt mice were inoculated with 1×10<sup>5</sup> B16-OVA cells and injected with 5×10<sup...
<p><b>A</b>) C57Bl6j mice were s.c. inoculated with 2.5×10<sup>5</sup>cells B16-F10 cells/mouse. 10 ...
<p>Tumor-bearing mice were treated with 10, 25 or 50 mg/kg of mAb AFS98 or PBS, IP, starting from da...
<p>F4/80 (A, B) or CD163 (C, D) expression in mammary tumors sampled at week 14 from mice treated wi...
Antibodies were administered locally into tumors again at days 2, 5, 8, and 11 after tumor transplan...
<p>Balb/c mice were inoculated with CT-26 cells and treated with WKYMVm, 5-FU, and mDCs according to...
<p>(<b>A</b>) CD8 TCRtg B6 mice injected with CD11c-scFv-IDRgag-treated bmDCs showed a significant h...
<p>Mice were subcutaneously immunized with PBS or TcdB-exposed CT26 cells (TcdB). In some experiment...
(A) EMT6 tumor growth measured as a tumor volume. (B) Percentage of intratumoral myeloid cells (in i...
C57BL/6 (WT) and PLT2 mice were challenged with B16.OVA tumor cells. CFSE-labelled OT-I T cells were...
<p>(<b>A</b>) Concentrations of various cytokines in ascites. A1, IL-6; A2, IL-12; A3, TNF-α; A4, IF...
C57BL/6 (WT) and PLT2 mice were challenged with B16 tumor cells and treated with peri-tumoral inject...
<p>(a) TNF-α concentration in the blood of <i>S.</i> Typhimurium-infected, CT26 tumor-bearing BALB/c...
<p><b>A</b>) and <b>B</b>) TNF-α and granzyme B levels, respectively, detected into tissue homogenat...
<p><b><i>1A</i></b><i>,</i> representative FACS plots for MDSC in blood, BM, spleen and tumor of 3LL...